tirzepatide-glycine Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity GobyMeds - Personalized Weight Loss

Your doctor will advise what is suitable for your goals

The role of Tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials

Pre-filled syringes should be used within 24 hours to minimize the risk of contamination or degradation

Friendly and Personalized Service Our friendly and personalized service is designed to make clients feel supported and valued throughout their journey

Therefore, drugs with a potent antihyperglycemic effect, independent of the glomerular filtration rate, with a low risk of hypoglycemia, that reduce weight in overweight/obese patients and that provide cardiovascular and renal protection, such as GLP-1 receptor agonists, are needed

These outcomes are described in cosmetic-research panels and pre-clinical models